Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navaneeth Narayanan

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|April 17, 2018
Results of a Hepatitis C Virus Screening Program of the 1945-1965 Birth Cohort in a Large Emergency Department in New JerseyJulia Kang Cornett, Vimal Bodiwala, Victor Razuk, et al.
Journal of the International Association of Providers of AIDS Care|May 30, 2026
Are People With HIV Aware of Their Cardiometabolic Risk? A Cross-Sectional Survey Study of People Living With HIV Within a Community Organization in an Urban SettingChristine Ann Dimaculangan Parikh, Brijesh Rana, Navaneeth Narayanan, et al.
Diagnostic Microbiology and Infectious Disease|August 16, 2021
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremiaMichael R Hovan, Navaneeth Narayanan, Vanessa Cedarbaum, et al.
CMI Communications|July 3, 2026
Are bactericidal antibiotics necessary to effectively treat bloodstream infections?Amy Pulikeyil, Emily G McDonald, Erin K McCreary, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Effectiveness of an Electronic Automated Antibiotic Time Out Alert in the Setting of Gram-Negative BacteremiaSana M Mohayya, Navaneeth Narayanan, Daniel Cimilluca, et al.
Therapeutic Advances in Infectious Disease|February 23, 2019
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremiaNavaneeth Narayanan, Rena Rai, Parth Vaidya, et al.
Hepatology (Baltimore, Md.)|December 6, 2019
Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United StatesMohamed I Elsaid, You Li, Tina John, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Evaluation of barriers to sustainable medication access in HondurasNavaneeth Narayanan, Sylvia S Stoffella, Arup Roy-Burman, et al.
Future Microbiology|March 1, 2024
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting <i>Acinetobacter baumannii</i>Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, et al.
Infection and Drug Resistance|November 23, 2018
Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of <i>Pseudomonas aeruginosa</i> infectionsMichael Hogan, Mary Barna Bridgeman, Gee Hee Min, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|April 17, 2018
Results of a Hepatitis C Virus Screening Program of the 1945-1965 Birth Cohort in a Large Emergency Department in New JerseyJulia Kang Cornett, Vimal Bodiwala, Victor Razuk, et al.
Journal of the International Association of Providers of AIDS Care|May 30, 2026
Are People With HIV Aware of Their Cardiometabolic Risk? A Cross-Sectional Survey Study of People Living With HIV Within a Community Organization in an Urban SettingChristine Ann Dimaculangan Parikh, Brijesh Rana, Navaneeth Narayanan, et al.
Diagnostic Microbiology and Infectious Disease|August 16, 2021
Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremiaMichael R Hovan, Navaneeth Narayanan, Vanessa Cedarbaum, et al.
CMI Communications|July 3, 2026
Are bactericidal antibiotics necessary to effectively treat bloodstream infections?Amy Pulikeyil, Emily G McDonald, Erin K McCreary, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Effectiveness of an Electronic Automated Antibiotic Time Out Alert in the Setting of Gram-Negative BacteremiaSana M Mohayya, Navaneeth Narayanan, Daniel Cimilluca, et al.
Therapeutic Advances in Infectious Disease|February 23, 2019
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremiaNavaneeth Narayanan, Rena Rai, Parth Vaidya, et al.
Hepatology (Baltimore, Md.)|December 6, 2019
Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United StatesMohamed I Elsaid, You Li, Tina John, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Evaluation of barriers to sustainable medication access in HondurasNavaneeth Narayanan, Sylvia S Stoffella, Arup Roy-Burman, et al.
Future Microbiology|March 1, 2024
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting <i>Acinetobacter baumannii</i>Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, et al.
Infection and Drug Resistance|November 23, 2018
Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of <i>Pseudomonas aeruginosa</i> infectionsMichael Hogan, Mary Barna Bridgeman, Gee Hee Min, et al.
Pageof 5